Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation

European Journal of Heart Failure

Volumn 8, Issue 7, 2006, Pages 712-715

  Bayrak, Fatih ^a,c   Komurcu Bayrak, Evrim ^b   Mutlu, Bulent ^a   Kahveci, Gokhan ^a   Basaran, Yelda ^a   Erginel Unaltuna, Nihan ^b  

^a KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Cardiomyopathy; Genetics; Ventricular pre excitation

Indexed keywords

ADENINE NUCLEOTIDE; GLUTAMIC ACID; GUANINE NUCLEOTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LYSINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; EXON; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART PREEXCITATION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 33750370906     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.03.006     Document Type: Article

References (14)

1. Maron B.J., McKenna W.J., Danielson G.K., et al. ACC/ESC clinical expert document on hypertophic cardiomypathy: a report of American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
2. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
3. Klues H.G., Schiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
4. Maron B.J., Bonow R.O., Cannon III R.O., Leon M.B., and Epstein S.E. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316 (1987) 844-852
5. Kemp B.E., Mitchelhill K.I., Stapleton D., Michell B.J., Chen Z.P., and Witters L.A. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 24 (1999) 22-25
6. Gollob M.H., Green M.S., Tang A.S., et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 344 (2001) 1823-1831
7. Blair E., Redwood C., Ashrafian H., et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 10 (2001) 1215-1220
8. Arad M., Benson D.W., Perez-Atayde A.R., et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 109 (2002) 357-362
9. Murphy R.T., Mogensen J., McGarry K., et al. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White Syndrome. J Am Coll Cardiol 45 (2005) 922-930
10. Gollob M.H., Seger J.J., Gollob T.N., et al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 104 (2001) 3030-3033
11. Arad M., Maron B.J., Gorham J.M., et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352 (2005) 362-372
12. Oliveira S.M.J., Ehtisham J., Redwood C.S., Ostman-Smith I., Blair E.M., and Watkins H. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis. J Mol Cell Cardiol 35 (2003) 1251-1255
13. Arad M., Moskowitz I.P., Patel V.V., et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 107 (2003) 2850-2856
14. Sidhu J.S., Rajawat Y.S., Rami T.G., et al. Transgenic Mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of function mutation responsible for Wolff-Parkinson-White syndrome. Circulation 111 (2005) 21-29